Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

SHA:688488 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,364	3,307	5,264	4,427	6,539	10,416
Market Cap Growth	137.45%	-37.17%	18.91%	-32.31%	-37.22%	-
Enterprise Value	7,531	3,402	5,147	4,084	5,910	9,620
Last Close Price	17.50	7.86	12.51	10.54	15.57	24.74
PE Ratio	-	-	-	-	-	261.89
PS Ratio	10.97	7.92	12.80	18.13	25.57	36.03
PB Ratio	6.81	3.10	4.68	3.69	4.99	7.66
P/TBV Ratio	11.39	5.22	5.28	4.14	5.60	8.06
P/FCF Ratio	-	-	-	-	-	758.11
P/OCF Ratio	-	-	-	-	-	185.44
EV/Sales Ratio	11.22	8.14	12.51	16.72	23.11	33.28
EV/EBITDA Ratio	-	-	-	-	-	173.66
EV/EBIT Ratio	-	-	-	-	-	284.91
EV/FCF Ratio	-315.19	-	-	-	-	700.21
Debt / Equity Ratio	0.45	0.46	0.37	0.17	0.00	-
Net Debt / Equity Ratio	0.06	0.04	-0.03	-0.23	-0.46	-0.57
Net Debt / EBITDA Ratio	-5.58	-0.45	0.45	2.01	17.11	-14.10
Net Debt / FCF Ratio	-2.65	-0.57	0.12	1.19	5.60	-56.84
Asset Turnover	0.36	0.23	0.24	0.16	0.18	0.26
Inventory Turnover	1.11	1.02	1.44	1.27	1.79	1.89
Quick Ratio	1.00	0.93	1.32	1.87	7.52	12.44
Current Ratio	1.42	1.38	1.78	2.42	8.94	13.79
Return on Equity (ROE)	-5.46%	-12.66%	-6.54%	-9.89%	-2.25%	4.15%
Return on Assets (ROA)	-2.08%	-5.24%	-3.90%	-6.94%	-2.70%	1.90%
Return on Invested Capital (ROIC)	-5.49%	-13.71%	-10.53%	-21.05%	-9.64%	5.00%
Return on Capital Employed (ROCE)	-5.20%	-12.40%	-8.50%	-13.00%	-4.60%	2.50%
Earnings Yield	-1.18%	-4.27%	-1.44%	-2.80%	-0.46%	0.38%
FCF Yield	-0.32%	-2.48%	-4.51%	-5.26%	-1.64%	0.13%
Dividend Yield	-	-	-	-	-	0.19%
Payout Ratio	-	-	-	-	-	7.86%
Buyback Yield / Dilution	21.13%	0.44%	-2.17%	3.44%	-7.71%	-6.38%
Total Shareholder Return	21.13%	0.44%	-2.17%	3.44%	-7.71%	-6.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.